GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc.
Your view on GEHC
Overview
What the company does, where it operates, and who runs it.
About GE HealthCare Technologies Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Peter J. Arduini
- Headquarters
- 500 West Monroe Street, Chicago, IL, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Peter J. Arduini
- Headquarters
- 500 West Monroe Street, Chicago, IL, US
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.
The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products.
The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products.
The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products.
The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry.
The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan.
The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for GE HealthCare Technologies Inc. from FRC's valuation model, read against the market price. GEHC last traded at $82.60, 17.5× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for GE HealthCare Technologies Inc.. Starting points for GE HealthCare Technologies Inc.: P/E 17.5, EPS $4.79, beta 0.77 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for GE HealthCare Technologies Inc.. GE HealthCare Technologies Inc. paid $0.14 per share over the last year — a 0.2% yield at the current $82.60 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for GE HealthCare Technologies Inc.. Trailing twelve-month EPS for GE HealthCare Technologies Inc. stands at $4.79. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
1-Year Price Target
Low
$67.00
Median
$80.00
High
$95.00
Average target · 1 new target in the last month, average $95.00
Analyst Ratings
- Strong Buy0
- Buy13
- Hold7
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.56 | $1.11 | $5.02 | $5.53 |
| Low estimate | $1.54 | $1.02 | $4.95 | $5.17 |
| High estimate | $1.60 | $1.19 | $5.06 | $5.74 |
| No. of analysts | 12 | 8 | 13 | 13 |
| Year-ago EPS | $1.29 | $0.85 | $4.55 | — |
| Growth | +20.7% | +30.9% | +10.4% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $5.92B | $5.36B | $21.87B | $22.94B |
| Low estimate | $5.86B | $5.34B | $21.82B | $22.76B |
| High estimate | $5.99B | $5.39B | $21.92B | $23.11B |
| No. of analysts | 11 | 6 | 16 | 14 |
| Year-ago revenue | $5.70B | $5.13B | $20.63B | — |
| Growth | +4.0% | +4.5% | +6.0% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 12, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for GE HealthCare Technologies Inc.. GE HealthCare Technologies Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
GE HealthCare Technologies Inc. valued side by side against its closest peers. GE HealthCare Technologies Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold GE HealthCare Technologies Inc., and how their positions are changing. At a $37.35B market value, institutional positions materially move GE HealthCare Technologies Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by GE HealthCare Technologies Inc. executives and directors. Shares of GE HealthCare Technologies Inc. have traded between $57.65 and $94.80 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming GE HealthCare Technologies Inc.. GE HealthCare Technologies Inc. is a $37.35B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming GE HealthCare Technologies Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for GE HealthCare Technologies Inc.. Coverage tracks GE HealthCare Technologies Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of GE HealthCare Technologies Inc.